The Ministry of Health of Antigua and Barbuda has registered the Russian anti-COVID19 vaccine Sputnik V, the Russian Direct Investment Fund (RDIF) reports.
Thus, the vaccine was approved in 57 countries with a total population of over 1.5 billion people. Registration of the drug was carried out as part of an accelerated procedure (emergency use authorization, EUA).
In terms of the number of approvals received by state regulators, Sputnik V ranks second in the world.
“Registration of the Sputnik V vaccine will help save the lives of many people and protect the population of Antigua and Barbuda. The high efficiency of Sputnik V was confirmed by the publication of data in the leading medical journal The Lancet. The Russian drug is one of the key tools for the prevention of coronavirus and is included in the vaccine portfolio of more than 50 countries, “said Kirill Dmitriev, CEO of the RDIF.
Currently, the use of the Sputnik V vaccine has also been approved in Russia, Belarus, Argentina, Bolivia, Serbia, Algeria, Palestine, Venezuela, Paraguay, Turkmenistan, Hungary, the UAE, Iran, the Republic of Guinea, Tunisia, Armenia, Mexico, Nicaragua, Republika Srpska (entity of Bosnia and Herzegovina), Lebanon, Myanmar, Pakistan, Mongolia, Bahrain, Montenegro, Saint Vincent and the Grenadines, Kazakhstan, Uzbekistan, Gabon, San Marino, Ghana, Syria, Kyrgyzstan, Guyana, Egypt, Honduras, Guatemala, Moldova, Slovakia, Angola, Djibouti, Republic of the Congo, Sri Lanka, Laos, Iraq, North Macedonia, Kenya, Morocco, Jordan, Namibia, Azerbaijan, Philippines, Cameroon, Seychelles, Mauritius and Vietnam.